ABBV vs MDT
By Alex · Tickerpine
AbbVie Inc. vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MDT |
|---|---|---|
| Price | $285.64 | $95.41 |
| Market cap | $504.76B | $122.04B |
| P/E ratio | 80.5 | 23.4 |
| ROE | — | 10.65% |
| Profit margin | 9.80% | 13.93% |
| Revenue growth | 10.20% | 13.70% |
| Dividend yield | 2.42% | 3.02% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MDT in plain English
- ABBV is the bigger company — about 4.1× the market cap of MDT.
- MDT is cheaper on earnings (P/E 23.4 vs 80.5).
- MDT is growing revenue faster (14% vs 10%).
- MDT has the higher dividend yield (3.02% vs 2.42%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.